Exploring how our microbiome influences cancer development and treatment response, with breakthrough research on microbial modulation of immunotherapy.
Breakthroughs in NEO-STIM™, an ex vivo T-cell training protocol, are creating armies of tumor-targeted assassins by harnessing neoantigens - cancer's unique molecular fingerprints.